ECM
MIRM icon

ExodusPoint Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

ExodusPoint Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-87,373
Closed -$8.07M – 1873
2026
Q1 		$8.07M Buy
+87,373
New +$8.22M 0.06% 290
2025
Q3 		– Sell
-34,175
Closed -$1.74M – 1836
2025
Q2 		$1.74M Sell
34,175
-2,087
-6% -$92.9K 0.02% 794
2025
Q1 		$1.63M Buy
36,262
+14,109
+64% +$665K 0.02% 767
2024
Q4 		$916K Buy
+22,153
New +$923K 0.01% 971
2024
Q3 		– Sell
-43,747
Closed -$1.5M – 1903
2024
Q2 		$1.5M Sell
43,747
-20,672
-32% -$542K 0.01% 887
2024
Q1 		$1.62M Buy
64,419
+31,237
+94% +$859K 0.01% 786
2023
Q4 		$980K Buy
+33,182
New +$1M 0.01% 828
2022
Q1 		– Sell
-52,474
Closed -$837K – 2490
2021
Q4 		$837K Buy
52,474
+25,221
+93% +$392K 0.01% 1165
2021
Q3 		$543K Buy
+27,253
New +$443K 0.01% 1331
2021
Q2 		– Sell
-14,570
Closed -$289K – 2630
2021
Q1 		$289K Buy
+14,570
New +$279K ﹤0.01% 1702
2020
Q3 		– Sell
-17,600
Closed -$342K – 2044
2020
Q2 		$342K Buy
+17,600
New +$294K 0.01% 1250

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ExodusPoint Capital Management's MIRM Position: Q2 2026 in Review

ExodusPoint Capital Management sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 87,373 shares — an estimated $8.07M sold.

ExodusPoint Capital Management first reported a position in MIRM in Q2 2020 and held it in 11 quarters. The position peaked at $8.07M in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • ExodusPoint Capital Management reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 87,373 Mirum Pharmaceuticals shares in Q2 2026, an estimated $8.07M.
  • ExodusPoint Capital Management first reported a position in Mirum Pharmaceuticals in Q2 2020 and held it in 11 quarters.
  • ExodusPoint Capital Management's Mirum Pharmaceuticals position peaked at $8.07M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.